Rasagiline Tablet Market, Global Outlook and Forecast 2023-2029

Publisher Name :
Date: 02-Feb-2023
No. of pages: 79

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.

This report aims to provide a comprehensive presentation of the global market for Rasagiline Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rasagiline Tablet. This report contains market size and forecasts of Rasagiline Tablet in global, including the following market information:

Global Rasagiline Tablet Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Rasagiline Tablet Market Sales, 2018-2023, 2024-2029, (M Pcs)

Global top five Rasagiline Tablet companies in 2022 (%)

The global Rasagiline Tablet market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identified it as a potential drug for Parkinson's disease, and working with collaborators at Technion - Israel Institute of Technology in Israel and the drug company, Teva Pharmaceutical, identified the R-isomer as the active form of the drug. Teva brought it to market in partnership with Lundbeck in Europe and Eisai in the US and elsewhere. It was approved in Europe in 2005 and in the US in 2006.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rasagiline Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rasagiline Tablet Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Pcs)

Global Rasagiline Tablet Market Segment Percentages, by Type, 2022 (%)

- 0.5 mg/Pcs

- 1 mg/Pcs

Global Rasagiline Tablet Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Pcs)

Global Rasagiline Tablet Market Segment Percentages, by Application, 2022 (%)

- Under 40 Years Old

- 40-65 Years Old

- Above 65 Years Old

Global Rasagiline Tablet Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Pcs)

Global Rasagiline Tablet Market Segment Percentages, By Region and Country, 2022 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rasagiline Tablet revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Rasagiline Tablet revenues share in global market, 2022 (%)

Key companies Rasagiline Tablet sales in global market, 2018-2023 (Estimated), (M Pcs)

Key companies Rasagiline Tablet sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Teva Pharmaceutical

- Lundbeck

- Sun Pharmaceutical

- Apotex

- Taj Pharma

- Mylan

- Takeda Pharmaceutical

- Sandoz

- Intas Pharmaceuticals

- Natco Pharma

- Ajanta Pharma

- Orchid Pharma

- Alkem Laboratories

Outline of Major Chapters:

Chapter 1: Introduces the definition of Rasagiline Tablet, market overview.

Chapter 2: Global Rasagiline Tablet market size in revenue and volume.

Chapter 3: Detailed analysis of Rasagiline Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rasagiline Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Rasagiline Tablet capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Rasagiline Tablet Market, Global Outlook and Forecast 2023-2029

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Rasagiline Tablet Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rasagiline Tablet Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rasagiline Tablet Overall Market Size
2.1 Global Rasagiline Tablet Market Size: 2022 VS 2029
2.2 Global Rasagiline Tablet Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Rasagiline Tablet Sales: 2018-2029
3 Company Landscape
3.1 Top Rasagiline Tablet Players in Global Market
3.2 Top Global Rasagiline Tablet Companies Ranked by Revenue
3.3 Global Rasagiline Tablet Revenue by Companies
3.4 Global Rasagiline Tablet Sales by Companies
3.5 Global Rasagiline Tablet Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Rasagiline Tablet Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Rasagiline Tablet Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rasagiline Tablet Players in Global Market
3.8.1 List of Global Tier 1 Rasagiline Tablet Companies
3.8.2 List of Global Tier 2 and Tier 3 Rasagiline Tablet Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Rasagiline Tablet Market Size Markets, 2022 & 2029
4.1.2 0.5 mg/Pcs
4.1.3 1 mg/Pcs
4.2 By Type - Global Rasagiline Tablet Revenue & Forecasts
4.2.1 By Type - Global Rasagiline Tablet Revenue, 2018-2023
4.2.2 By Type - Global Rasagiline Tablet Revenue, 2024-2029
4.2.3 By Type - Global Rasagiline Tablet Revenue Market Share, 2018-2029
4.3 By Type - Global Rasagiline Tablet Sales & Forecasts
4.3.1 By Type - Global Rasagiline Tablet Sales, 2018-2023
4.3.2 By Type - Global Rasagiline Tablet Sales, 2024-2029
4.3.3 By Type - Global Rasagiline Tablet Sales Market Share, 2018-2029
4.4 By Type - Global Rasagiline Tablet Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rasagiline Tablet Market Size, 2022 & 2029
5.1.2 Under 40 Years Old
5.1.3 40-65 Years Old
5.1.4 Above 65 Years Old
5.2 By Application - Global Rasagiline Tablet Revenue & Forecasts
5.2.1 By Application - Global Rasagiline Tablet Revenue, 2018-2023
5.2.2 By Application - Global Rasagiline Tablet Revenue, 2024-2029
5.2.3 By Application - Global Rasagiline Tablet Revenue Market Share, 2018-2029
5.3 By Application - Global Rasagiline Tablet Sales & Forecasts
5.3.1 By Application - Global Rasagiline Tablet Sales, 2018-2023
5.3.2 By Application - Global Rasagiline Tablet Sales, 2024-2029
5.3.3 By Application - Global Rasagiline Tablet Sales Market Share, 2018-2029
5.4 By Application - Global Rasagiline Tablet Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Rasagiline Tablet Market Size, 2022 & 2029
6.2 By Region - Global Rasagiline Tablet Revenue & Forecasts
6.2.1 By Region - Global Rasagiline Tablet Revenue, 2018-2023
6.2.2 By Region - Global Rasagiline Tablet Revenue, 2024-2029
6.2.3 By Region - Global Rasagiline Tablet Revenue Market Share, 2018-2029
6.3 By Region - Global Rasagiline Tablet Sales & Forecasts
6.3.1 By Region - Global Rasagiline Tablet Sales, 2018-2023
6.3.2 By Region - Global Rasagiline Tablet Sales, 2024-2029
6.3.3 By Region - Global Rasagiline Tablet Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Rasagiline Tablet Revenue, 2018-2029
6.4.2 By Country - North America Rasagiline Tablet Sales, 2018-2029
6.4.3 US Rasagiline Tablet Market Size, 2018-2029
6.4.4 Canada Rasagiline Tablet Market Size, 2018-2029
6.4.5 Mexico Rasagiline Tablet Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Rasagiline Tablet Revenue, 2018-2029
6.5.2 By Country - Europe Rasagiline Tablet Sales, 2018-2029
6.5.3 Germany Rasagiline Tablet Market Size, 2018-2029
6.5.4 France Rasagiline Tablet Market Size, 2018-2029
6.5.5 U.K. Rasagiline Tablet Market Size, 2018-2029
6.5.6 Italy Rasagiline Tablet Market Size, 2018-2029
6.5.7 Russia Rasagiline Tablet Market Size, 2018-2029
6.5.8 Nordic Countries Rasagiline Tablet Market Size, 2018-2029
6.5.9 Benelux Rasagiline Tablet Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Rasagiline Tablet Revenue, 2018-2029
6.6.2 By Region - Asia Rasagiline Tablet Sales, 2018-2029
6.6.3 China Rasagiline Tablet Market Size, 2018-2029
6.6.4 Japan Rasagiline Tablet Market Size, 2018-2029
6.6.5 South Korea Rasagiline Tablet Market Size, 2018-2029
6.6.6 Southeast Asia Rasagiline Tablet Market Size, 2018-2029
6.6.7 India Rasagiline Tablet Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Rasagiline Tablet Revenue, 2018-2029
6.7.2 By Country - South America Rasagiline Tablet Sales, 2018-2029
6.7.3 Brazil Rasagiline Tablet Market Size, 2018-2029
6.7.4 Argentina Rasagiline Tablet Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rasagiline Tablet Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Rasagiline Tablet Sales, 2018-2029
6.8.3 Turkey Rasagiline Tablet Market Size, 2018-2029
6.8.4 Israel Rasagiline Tablet Market Size, 2018-2029
6.8.5 Saudi Arabia Rasagiline Tablet Market Size, 2018-2029
6.8.6 UAE Rasagiline Tablet Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Teva Pharmaceutical
7.1.1 Teva Pharmaceutical Company Summary
7.1.2 Teva Pharmaceutical Business Overview
7.1.3 Teva Pharmaceutical Rasagiline Tablet Major Product Offerings
7.1.4 Teva Pharmaceutical Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.1.5 Teva Pharmaceutical Key News & Latest Developments
7.2 Lundbeck
7.2.1 Lundbeck Company Summary
7.2.2 Lundbeck Business Overview
7.2.3 Lundbeck Rasagiline Tablet Major Product Offerings
7.2.4 Lundbeck Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.2.5 Lundbeck Key News & Latest Developments
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Company Summary
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Rasagiline Tablet Major Product Offerings
7.3.4 Sun Pharmaceutical Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.3.5 Sun Pharmaceutical Key News & Latest Developments
7.4 Apotex
7.4.1 Apotex Company Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Rasagiline Tablet Major Product Offerings
7.4.4 Apotex Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.4.5 Apotex Key News & Latest Developments
7.5 Taj Pharma
7.5.1 Taj Pharma Company Summary
7.5.2 Taj Pharma Business Overview
7.5.3 Taj Pharma Rasagiline Tablet Major Product Offerings
7.5.4 Taj Pharma Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.5.5 Taj Pharma Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Rasagiline Tablet Major Product Offerings
7.6.4 Mylan Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Company Summary
7.7.2 Takeda Pharmaceutical Business Overview
7.7.3 Takeda Pharmaceutical Rasagiline Tablet Major Product Offerings
7.7.4 Takeda Pharmaceutical Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.7.5 Takeda Pharmaceutical Key News & Latest Developments
7.8 Sandoz
7.8.1 Sandoz Company Summary
7.8.2 Sandoz Business Overview
7.8.3 Sandoz Rasagiline Tablet Major Product Offerings
7.8.4 Sandoz Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.8.5 Sandoz Key News & Latest Developments
7.9 Intas Pharmaceuticals
7.9.1 Intas Pharmaceuticals Company Summary
7.9.2 Intas Pharmaceuticals Business Overview
7.9.3 Intas Pharmaceuticals Rasagiline Tablet Major Product Offerings
7.9.4 Intas Pharmaceuticals Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.9.5 Intas Pharmaceuticals Key News & Latest Developments
7.10 Natco Pharma
7.10.1 Natco Pharma Company Summary
7.10.2 Natco Pharma Business Overview
7.10.3 Natco Pharma Rasagiline Tablet Major Product Offerings
7.10.4 Natco Pharma Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.10.5 Natco Pharma Key News & Latest Developments
7.11 Ajanta Pharma
7.11.1 Ajanta Pharma Company Summary
7.11.2 Ajanta Pharma Rasagiline Tablet Business Overview
7.11.3 Ajanta Pharma Rasagiline Tablet Major Product Offerings
7.11.4 Ajanta Pharma Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.11.5 Ajanta Pharma Key News & Latest Developments
7.12 Orchid Pharma
7.12.1 Orchid Pharma Company Summary
7.12.2 Orchid Pharma Rasagiline Tablet Business Overview
7.12.3 Orchid Pharma Rasagiline Tablet Major Product Offerings
7.12.4 Orchid Pharma Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.12.5 Orchid Pharma Key News & Latest Developments
7.13 Alkem Laboratories
7.13.1 Alkem Laboratories Company Summary
7.13.2 Alkem Laboratories Rasagiline Tablet Business Overview
7.13.3 Alkem Laboratories Rasagiline Tablet Major Product Offerings
7.13.4 Alkem Laboratories Rasagiline Tablet Sales and Revenue in Global (2018-2023)
7.13.5 Alkem Laboratories Key News & Latest Developments
8 Global Rasagiline Tablet Production Capacity, Analysis
8.1 Global Rasagiline Tablet Production Capacity, 2018-2029
8.2 Rasagiline Tablet Production Capacity of Key Manufacturers in Global Market
8.3 Global Rasagiline Tablet Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rasagiline Tablet Supply Chain Analysis
10.1 Rasagiline Tablet Industry Value Chain
10.2 Rasagiline Tablet Upstream Market
10.3 Rasagiline Tablet Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rasagiline Tablet Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Rasagiline Tablet in Global Market
Table 2. Top Rasagiline Tablet Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Rasagiline Tablet Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Rasagiline Tablet Revenue Share by Companies, 2018-2023
Table 5. Global Rasagiline Tablet Sales by Companies, (M Pcs), 2018-2023
Table 6. Global Rasagiline Tablet Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Rasagiline Tablet Price (2018-2023) & (USD/K Pcs)
Table 8. Global Manufacturers Rasagiline Tablet Product Type
Table 9. List of Global Tier 1 Rasagiline Tablet Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rasagiline Tablet Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Rasagiline Tablet Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Rasagiline Tablet Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Rasagiline Tablet Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Rasagiline Tablet Sales (M Pcs), 2018-2023
Table 15. By Type - Global Rasagiline Tablet Sales (M Pcs), 2024-2029
Table 16. By Application - Global Rasagiline Tablet Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Rasagiline Tablet Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Rasagiline Tablet Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Rasagiline Tablet Sales (M Pcs), 2018-2023
Table 20. By Application - Global Rasagiline Tablet Sales (M Pcs), 2024-2029
Table 21. By Region - Global Rasagiline Tablet Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Rasagiline Tablet Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Rasagiline Tablet Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Rasagiline Tablet Sales (M Pcs), 2018-2023
Table 25. By Region - Global Rasagiline Tablet Sales (M Pcs), 2024-2029
Table 26. By Country - North America Rasagiline Tablet Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Rasagiline Tablet Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Rasagiline Tablet Sales, (M Pcs), 2018-2023
Table 29. By Country - North America Rasagiline Tablet Sales, (M Pcs), 2024-2029
Table 30. By Country - Europe Rasagiline Tablet Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Rasagiline Tablet Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Rasagiline Tablet Sales, (M Pcs), 2018-2023
Table 33. By Country - Europe Rasagiline Tablet Sales, (M Pcs), 2024-2029
Table 34. By Region - Asia Rasagiline Tablet Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Rasagiline Tablet Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Rasagiline Tablet Sales, (M Pcs), 2018-2023
Table 37. By Region - Asia Rasagiline Tablet Sales, (M Pcs), 2024-2029
Table 38. By Country - South America Rasagiline Tablet Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Rasagiline Tablet Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Rasagiline Tablet Sales, (M Pcs), 2018-2023
Table 41. By Country - South America Rasagiline Tablet Sales, (M Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Rasagiline Tablet Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Rasagiline Tablet Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Rasagiline Tablet Sales, (M Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Rasagiline Tablet Sales, (M Pcs), 2024-2029
Table 46. Teva Pharmaceutical Company Summary
Table 47. Teva Pharmaceutical Rasagiline Tablet Product Offerings
Table 48. Teva Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 49. Teva Pharmaceutical Key News & Latest Developments
Table 50. Lundbeck Company Summary
Table 51. Lundbeck Rasagiline Tablet Product Offerings
Table 52. Lundbeck Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 53. Lundbeck Key News & Latest Developments
Table 54. Sun Pharmaceutical Company Summary
Table 55. Sun Pharmaceutical Rasagiline Tablet Product Offerings
Table 56. Sun Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 57. Sun Pharmaceutical Key News & Latest Developments
Table 58. Apotex Company Summary
Table 59. Apotex Rasagiline Tablet Product Offerings
Table 60. Apotex Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 61. Apotex Key News & Latest Developments
Table 62. Taj Pharma Company Summary
Table 63. Taj Pharma Rasagiline Tablet Product Offerings
Table 64. Taj Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 65. Taj Pharma Key News & Latest Developments
Table 66. Mylan Company Summary
Table 67. Mylan Rasagiline Tablet Product Offerings
Table 68. Mylan Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 69. Mylan Key News & Latest Developments
Table 70. Takeda Pharmaceutical Company Summary
Table 71. Takeda Pharmaceutical Rasagiline Tablet Product Offerings
Table 72. Takeda Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 73. Takeda Pharmaceutical Key News & Latest Developments
Table 74. Sandoz Company Summary
Table 75. Sandoz Rasagiline Tablet Product Offerings
Table 76. Sandoz Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 77. Sandoz Key News & Latest Developments
Table 78. Intas Pharmaceuticals Company Summary
Table 79. Intas Pharmaceuticals Rasagiline Tablet Product Offerings
Table 80. Intas Pharmaceuticals Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 81. Intas Pharmaceuticals Key News & Latest Developments
Table 82. Natco Pharma Company Summary
Table 83. Natco Pharma Rasagiline Tablet Product Offerings
Table 84. Natco Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 85. Natco Pharma Key News & Latest Developments
Table 86. Ajanta Pharma Company Summary
Table 87. Ajanta Pharma Rasagiline Tablet Product Offerings
Table 88. Ajanta Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 89. Ajanta Pharma Key News & Latest Developments
Table 90. Orchid Pharma Company Summary
Table 91. Orchid Pharma Rasagiline Tablet Product Offerings
Table 92. Orchid Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 93. Orchid Pharma Key News & Latest Developments
Table 94. Alkem Laboratories Company Summary
Table 95. Alkem Laboratories Rasagiline Tablet Product Offerings
Table 96. Alkem Laboratories Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/K Pcs) (2018-2023)
Table 97. Alkem Laboratories Key News & Latest Developments
Table 98. Rasagiline Tablet Production Capacity (M Pcs) of Key Manufacturers in Global Market, 2021-2023 (M Pcs)
Table 99. Global Rasagiline Tablet Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Rasagiline Tablet Production by Region, 2018-2023 (M Pcs)
Table 101. Global Rasagiline Tablet Production by Region, 2024-2029 (M Pcs)
Table 102. Rasagiline Tablet Market Opportunities & Trends in Global Market
Table 103. Rasagiline Tablet Market Drivers in Global Market
Table 104. Rasagiline Tablet Market Restraints in Global Market
Table 105. Rasagiline Tablet Raw Materials
Table 106. Rasagiline Tablet Raw Materials Suppliers in Global Market
Table 107. Typical Rasagiline Tablet Downstream
Table 108. Rasagiline Tablet Downstream Clients in Global Market
Table 109. Rasagiline Tablet Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Rasagiline Tablet Segment by Type in 2022
Figure 2. Rasagiline Tablet Segment by Application in 2022
Figure 3. Global Rasagiline Tablet Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rasagiline Tablet Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rasagiline Tablet Revenue, 2018-2029 (US$, Mn)
Figure 7. Rasagiline Tablet Sales in Global Market: 2018-2029 (M Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Rasagiline Tablet Revenue in 2022
Figure 9. By Type - Global Rasagiline Tablet Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Rasagiline Tablet Revenue Market Share, 2018-2029
Figure 11. By Type - Global Rasagiline Tablet Sales Market Share, 2018-2029
Figure 12. By Type - Global Rasagiline Tablet Price (USD/K Pcs), 2018-2029
Figure 13. By Application - Global Rasagiline Tablet Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Rasagiline Tablet Revenue Market Share, 2018-2029
Figure 15. By Application - Global Rasagiline Tablet Sales Market Share, 2018-2029
Figure 16. By Application - Global Rasagiline Tablet Price (USD/K Pcs), 2018-2029
Figure 17. By Region - Global Rasagiline Tablet Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Rasagiline Tablet Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Rasagiline Tablet Revenue Market Share, 2018-2029
Figure 20. By Region - Global Rasagiline Tablet Sales Market Share, 2018-2029
Figure 21. By Country - North America Rasagiline Tablet Revenue Market Share, 2018-2029
Figure 22. By Country - North America Rasagiline Tablet Sales Market Share, 2018-2029
Figure 23. US Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Rasagiline Tablet Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Rasagiline Tablet Sales Market Share, 2018-2029
Figure 28. Germany Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 29. France Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Rasagiline Tablet Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Rasagiline Tablet Sales Market Share, 2018-2029
Figure 37. China Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 41. India Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Rasagiline Tablet Revenue Market Share, 2018-2029
Figure 43. By Country - South America Rasagiline Tablet Sales Market Share, 2018-2029
Figure 44. Brazil Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Rasagiline Tablet Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Rasagiline Tablet Sales Market Share, 2018-2029
Figure 48. Turkey Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Rasagiline Tablet Revenue, (US$, Mn), 2018-2029
Figure 52. Global Rasagiline Tablet Production Capacity (M Pcs), 2018-2029
Figure 53. The Percentage of Production Rasagiline Tablet by Region, 2022 VS 2029
Figure 54. Rasagiline Tablet Industry Value Chain
Figure 55. Marketing Channels
  • Global Parkinson's Disease Therapeutics Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99
    Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
  • Global Amantadine Hydrochloride Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
  • Global Rasagiline Tablet Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107
    Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
  • Global Parkinsons Disease Drug Market Insights, Forecast to 2029
    Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113
    Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......
  • Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Amantadine Hydrochloride Market Research Report 2023
    Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......
  • Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs